載入...

Bispecific antibodies for cancer therapy: The light at the end of the tunnel?

With 23 approvals in the US and other countries and four approvals outside US, antibodies are now widely recognized as therapeutic molecules. The therapeutic and commercial successes met by rituximab, trastuzumab, cetuximab and other mAbs have inspired antibody engineers to improve the efficacy of t...

全面介紹

Na minha lista:
書目詳細資料
Main Authors: Chames, Patrick, Baty, Daniel
格式: Artigo
語言:Inglês
出版: Landes Bioscience 2009
主題:
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC2791310/
https://ncbi.nlm.nih.gov/pubmed/20073127
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!